T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas

L.S. Politi; G. Brugnara; A. Castellano; M. Cadioli; L. Altabella; M. Peviani; S. Mazzoleni; A. Falini; R. Galli

doi:10.3174/ajnr.A4774

Letter

T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas

L.S. Politi, G. Brugnara, A. Castellano, M. Cadioli, L. Altabella, M. Peviani, S. Mazzoleni, A. Falini and R. Galli

American Journal of Neuroradiology June 2016, 37 (6) E49-E51; DOI: https://doi.org/10.3174/ajnr.A4774

L.S. Politi

aNeuroimaging Research, Hematology/Oncology Division Boston Children's Hospital/Dana Farber Cancer Institute Boston, Massachusetts

bRadiology Department University of Massachusetts Medical School Worcester, Massachusetts

cNeuroradiology Unit and CERMAC Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for L.S. Politi

G. Brugnara

dNeuroradiology Unit and CERMAC Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for G. Brugnara

A. Castellano

dNeuroradiology Unit and CERMAC Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for A. Castellano

M. Cadioli

dNeuroradiology Unit and CERMAC Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for M. Cadioli

L. Altabella

dNeuroradiology Unit and CERMAC Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for L. Altabella

M. Peviani

eNeuroimaging Research, Hematology/Oncology Division Boston Children's Hospital/Dana Farber Cancer Institute Boston, Massachusetts

fNeuroradiology Unit and CERMAC Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for M. Peviani

S. Mazzoleni

gNeural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for S. Mazzoleni

A. Falini

hNeuroradiology Unit and CERMAC Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for A. Falini

R. Galli

iNeural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy IRCCS San Raffaele Scientific Institute, Milan, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for R. Galli

Article
Figures & Data
Info & Metrics
Responses
References
PDF

References

1.↵
2. Arevalo-Perez J,
3. Thomas AA,
4. Kaley T, et al
. T1-weighted dynamic contrast-enhanced MRI as a noninvasive biomarker of epidermal growth factor receptor vIII status. AJNR Am J Neuroradiol 2015;36:2256–61 doi:10.3174/ajnr.A4484 pmid:26338913
Abstract/FREE Full Text
2.↵
2. Mazzoleni S,
3. Politi LS,
4. Pala M, et al
. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 2010;70:7500–13 doi:10.1158/0008-5472.CAN-10-2353 pmid:20858720
Abstract/FREE Full Text

PreviousNext

In this issue

American Journal of Neuroradiology

Vol. 37, Issue 6

1 Jun 2016

Table of Contents
Index by author
Complete Issue (PDF)

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

L.S. Politi, G. Brugnara, A. Castellano, M. Cadioli, L. Altabella, M. Peviani, S. Mazzoleni, A. Falini, R. Galli

T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas

American Journal of Neuroradiology Jun 2016, 37 (6) E49-E51; DOI: 10.3174/ajnr.A4774

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas

L.S. Politi, G. Brugnara, A. Castellano, M. Cadioli, L. Altabella, M. Peviani, S. Mazzoleni, A. Falini, R. Galli

American Journal of Neuroradiology Jun 2016, 37 (6) E49-E51; DOI: 10.3174/ajnr.A4774

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
- Footnotes
- References
Figures & Data
Info & Metrics
Responses
References
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas

Crossref (5)
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas

Berta Segura-Collar, María Garranzo-Asensio, Beatriz Herranz, Esther Hernández-SanMiguel, Teresa Cejalvo, Bárbara S. Casas, Ander Matheu, Ángel Pérez-Núñez, Juan Manuel Sepúlveda-Sánchez, Aurelio Hernández-Laín, Verónica Palma, Ricardo Gargini, Pilar Sánchez-Gómez

Cancer Research 2021 81 8
Progress in neuro-imaging of brain tumors

Antonella Castellano, Andrea Falini

Current Opinion in Oncology 2016 28 6
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma

Silvia Valtorta, Alessia Lo Dico, Isabella Raccagni, Cristina Martelli, Valentina Pieri, Paolo Rainone, Sergio Todde, Bastian Zinnhardt, Elisabetta De Bernardi, Angela Coliva, Letterio S. Politi, Thomas Viel, Andreas H. Jacobs, Rossella Galli, Luisa Ottobrini, Valentina Vaira, Rosa Maria Moresco

Frontiers in Oncology 2021 11
Advancing Imaging to Enhance Surgery

Marco Riva, Egesta Lopci, Lorenzo G. Gay, Marco Conti Nibali, Marco Rossi, Tommaso Sciortino, Antonella Castellano, Lorenzo Bello

Neurosurgery Clinics of North America 2021 32 1
Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance/high-resolution fluorescence imaging in rat models of glioblastoma

Marco Peviani, Giorgia Spano, Antonella Pagani, Gianluca Brugnara, Cesare Covino, Rossella Galli, Alessandra Biffi, Letterio S. Politi

Scientific Reports 2020 10 1

[1] 1.↵

Arevalo-Perez J,
Thomas AA,
Kaley T, et al
. T1-weighted dynamic contrast-enhanced MRI as a noninvasive biomarker of epidermal growth factor receptor vIII status. AJNR Am J Neuroradiol 2015;36:2256–61 doi:10.3174/ajnr.A4484 pmid:26338913
Abstract/FREE Full Text

[3] Arevalo-Perez J,

[4] Thomas AA,

[5] Kaley T, et al

[6] 2.↵

Mazzoleni S,
Politi LS,
Pala M, et al
. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 2010;70:7500–13 doi:10.1158/0008-5472.CAN-10-2353 pmid:20858720
Abstract/FREE Full Text

[8] Mazzoleni S,

[9] Politi LS,

[10] Pala M, et al

Main menu

User menu

Search

American Journal of Neuroradiology

T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

Similar Articles

Indexed Content

Cases

More from AJNR

Multimedia

Resources

About Us

American Society of Neuroradiology